Advertisement

Topics

Latest "Frederick County Office of Economic Development" News Stories

01:38 EST 18th November 2018 | BioPortfolio

Here are the most relevant search results for "Frederick County Office of Economic Development" found in our extensive news archives from over 250 global news sources.

More Information about Frederick County Office of Economic Development on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about Frederick County Office of Economic Development for you to read. Along with our medical data and news we also list Frederick County Office of Economic Development Clinical Trials, which are updated daily. BioPortfolio also has a large database of Frederick County Office of Economic Development Companies for you to search.

Showing "Frederick County Office Economic Development" News Articles 1–25 of 19,000+

Sunday 18th November 2018

Global and Asia Pyrogallol Acid Market Status and Future Forecast 20132023 [Report Updated: 21082018] Prices from USD $3000

SummaryKey Content of Chapters Including and can be customizedPart 1:Market Overview, Development, and Segment by Type, Application RegionPart 2:Global Market by company, Type, Application RegionPart 3:Asia Market by company, Type, Application RegionPart 410:Key Regions of Asia Market by Type, ApplicationPart 11:Company information, Sales, Cost, Margin etc.Part 12:ConclusionMarket Segment as fo...


RaQualia Pharma Inc 4579 Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 23102018] Prices from USD $250

SummaryRaQualia Pharma Inc RaQualia is a drug development company that discovers and develops pharmaceutical compounds. The company offers products such as anidulafungin, ziprasidone, dalbavancin, 5HT2B antagonist, motilin receptor agonist, potassiumcompetitive acid blockerand 5HT4 partial agonist. Its products are used in the treatment of gastroparesis, chronic constipation, neuropathic pain, ano...

Saturday 17th November 2018

Homozygous Familial Hypercholesterolemia HoFH Pipeline Review, H2 2018 [Report Updated: 13112018] Prices from USD $2000

Homozygous Familial Hypercholesterolemia HoFH Pipeline Review, H2 2018SummaryGlobal Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Homozygous Familial Hypercholesterolemia Pipeline Review, H2 2018, provides an overview of the Homozygous Familial Hypercholesterolemia Metabolic Disorders pipeline landscape.Homozygous familial hypercholesterolemia is a genetic disorder...


Lumosa Therapeutics Co Ltd 6535 Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 23102018] Prices from USD $250

SummaryLumosa Therapeutics Co Ltd Lumosa Therapeutics is a developer of drugs for the treatment of neurological and inflammatory diseases. The company's pipeline products include LT1001, an analgesic injection for severe pain relief; and LT3001, a novel small molecule for acute ischemic stroke. Its activities comprise chemical development, translational research, preclinical, intellectual property...

Alchemia Ltd ACL Financial and Strategic SWOT Analysis Review [Report Updated: 08112018] Prices from USD $125

Alchemia Ltd ACL Financial and Strategic SWOT Analysis Review provides you an indepth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company's key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your busi...

CASI Pharmaceuticals Inc CASI Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 09112018] Prices from USD $250

SummaryCASI Pharmaceuticals Inc CASI is a biopharmaceutical company, which focuses on the acquisition, development and commercialization of innovative therapies for treating cancer and other unmet medical needs. Its pipeline product portfolio includes ENMD2076 that is being developed globally for the treatment of various cancers including triplenegative breast cancer, softtissue sarcoma, ovarian c...

Global and Asia Tetrapropylammonium Bromide Market Status and Future Forecast 20132023 [Report Updated: 20082018] Prices from USD $3000

SummaryKey Content of Chapters Including and can be customizedPart 1:Market Overview, Development, and Segment by Type, Application RegionPart 2:Global Market by company, Type, Application RegionPart 3:Asia Market by company, Type, Application RegionPart 410:Key Regions of Asia Market by Type, ApplicationPart 11:Company information, Sales, Cost, Margin etc.Part 12:ConclusionMarket Segment as fo...

Idiopathic Pulmonary Fibrosis Pipeline Review, H2 2018 [Report Updated: 31102018] Prices from USD $2000

Idiopathic Pulmonary Fibrosis Pipeline Review, H2 2018SummaryGlobal Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Idiopathic Pulmonary Fibrosis Pipeline Review, H2 2018, provides an overview of the Idiopathic Pulmonary Fibrosis Respiratory pipeline landscape.Idiopathic pulmonary fibrosis IPF is a progressive and fatal disease characterized by inflammation and scarr...

Centre for Commercialization of Regenerative Medicine Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 08112018] Prices from USD $250

SummaryCentre for Commercialization of Regenerative Medicine CCRM is a healthcare service provider that offers cell reprogramming and engineering, cell manufacturing, biomaterials and devices manufacturing, and protocol development services. The center harnesses the power of stem cells, biomaterials and molecules to repair, regenerate or replace diseased cells, tissues and organs. It provides busi...

Johns Hopkins University Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 12102018] Prices from USD $250

SummaryJohns Hopkins University JHU is a research university which offers undergraduate, graduate, master's, and doctoral programs. It offers educational services in the areas of arts and sciences, engineering, business, medicine, nursing, public health, and advanced international studies. It also conducts research and developments programs on applied physics, projects administration, natural scie...

Alzheimer's Drug Discovery Foundation Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 08112018] Prices from USD $250

SummaryAlzheimer's Drug Discovery Foundation ADDF, formerly Institute for the Study of Aging is a drug discovery foundation. The foundation offers funds for drug discovery and development research programs in the field of Alzheimer's disease, related dementias and cognitive aging. It offers services and support for development of drugs to prevent, treat, and cure Alzheimer's disease. ADDF provides...

Norovirus strikes shelters for California wildfire evacuees – WCPO

WCPONorovirus strikes shelters for California wildfire evacueesWCPOEvacuees who fled the Camp Fire in California are facing norovirus outbreaks in shelters. The Butte County Public Health Department said that 145 people have been sick with vomiting and/or diarrhea since the shelters opened to evacuees and 41 people ...California Fire Victims now face NorovirusFood Poison JournalHundreds of Camp Fi...

GeoVax Labs Inc GOVX Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 09112018] Prices from USD $250

SummaryGeoVax Labs Inc GeoVax develops human vaccines for diseases caused by human immunodeficiency virus HIV, cancer and other infectious diseases using Modified Vaccinia Ankara VirusLike Particle MVAVLP vaccine platform. The company's vaccine development programs focus on HIV, Zika virus and hemorrhagic fever viruses Ebola, Marburg, Lassa fever and for cancer immunotherapy. Its advanced vaccines...

EndStage Kidney Disease EndStage Renal Disease or ESRD Pipeline Review, H2 2018 [Report Updated: 13112018] Prices from USD $2000

EndStage Kidney Disease EndStage Renal Disease or ESRD Pipeline Review, H2 2018SummaryGlobal Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide EndStage Kidney Disease Pipeline Review, H2 2018, provides an overview of the EndStage Kidney Disease Genito Urinary System And Sex Hormones pipeline landscape.Endstage kidney disease is the complete or almost complete failure o...

Inhibitor of Nuclear Factor Kappa B Kinase Subunit Beta Nuclear Factor NF Kappa B Inhibitor Kinase Beta or I Kappa B Kinase 2 or IKBKB or EC 2.7.11.10 Pipeline Review, H2 2018 [Report Updated: 14082018] Prices from USD $3500

Inhibitor of Nuclear Factor Kappa B Kinase Subunit Beta Nuclear Factor NF Kappa B Inhibitor Kinase Beta or I Kappa B Kinase 2 or IKBKB or EC 2.7.11.10 Pipeline Review, H2 2018SummaryInhibitor of Nuclear Factor Kappa B Kinase Subunit Beta Nuclear Factor NF Kappa B Inhibitor Kinase Beta or I Kappa B Kinase 2 or IKBKB or EC 2.7.11.10 pipeline Target constitutes close to 8 molecules. Out of which app...

hVIVO Plc HVO Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 23102018] Prices from USD $250

SummaryhVIVO Plc hVIVO, formerly Retroscreen Virology Ltd is a biopharma company that develops humanbased analytical platform to accelerate drug discovery and development. The company enables organisations to discover drugs and diagnostics and accelerate new product development. It uses human disease model platform to study new drugs and investigate diseases. hVIVO offers services such as viral ch...

Global and Asia Lithium Aluminium Hydride LAH Market Status and Future Forecast 20132023 [Report Updated: 20082018] Prices from USD $3000

SummaryKey Content of Chapters Including and can be customizedPart 1:Market Overview, Development, and Segment by Type, Application RegionPart 2:Global Market by company, Type, Application RegionPart 3:Asia Market by company, Type, Application RegionPart 410:Key Regions of Asia Market by Type, ApplicationPart 11:Company information, Sales, Cost, Margin etc.Part 12:ConclusionMarket Segment as fo...

AstraZeneca phase III MYSTIC trial of Imfinzi and tremelimumab in stage IV NSCLC fails to meet primary endpoint

AstraZeneca and MedImmune, its global biologics research and development arm, announced final overall survival (OS) results for the phase III MYSTIC trial, a randomised, open─label, multi─centre, global trial

Alpha Galactosidase A Alpha DGalactosidase A or Alpha D Galactoside Galactohydrolase or Melibiase or Agalsidase or GLA or EC 3.2.1.22 Pipeline Review, H2 2018 [Report Updated: 16102018] Prices from USD $3500

Alpha Galactosidase A Alpha DGalactosidase A or Alpha D Galactoside Galactohydrolase or Melibiase or Agalsidase or GLA or EC 3.2.1.22 Pipeline Review, H2 2018SummaryAlpha Galactosidase A Alpha DGalactosidase A or Alpha D Galactoside Galactohydrolase or Melibiase or Agalsidase or GLA or EC 3.2.1.22 Alphagalactosidase is a glycoside hydrolase enzyme encoded by the GLA gene. This enzyme is a homodi...

BioStem Technologies Inc BSEM Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 08112018] Prices from USD $250

SummaryBioStem Technologies Inc. BioStem Technologies, formerly Caribbean International Holdings Inc., is a life sciences company that discovers, develops and manufactures pharmaceuticals and regenerative medicines. Through its subsidiaries, the company discovers, develops, produces and commercializes stem cell and wellness products. It provides regenerative biologics for the treatment of muscular...

Pharnext SA ALPHA Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 23102018] Prices from USD $250

SummaryPharnext SA Pharnext, formerly Pharnext SAS is a biopharmaceutical company that develops novel therapies for severe neurodegenerative diseases. The company offers pleotherapy, a proprietary research and development platform based on network pharmacology that uses wide genomic data to identify molecules related to specific diseases and facilitates the development of synergistic combinations ...

Direct Biologics, LLC Has Acquired Paisley Laboratories, LLC

ST. LOUIS, Nov 17, 2018 /PRNewswire/ -- DirectBiologics, LLC announces the acquisition of Paisley Laboratories, LLC. The mission of these combined research and development companies Read more...

Friday 16th November 2018

"Belt Road Innovation and Development Collaboration Forum" and ...

SHENZHEN, China, Nov. 17, 2018 /PRNewswire/ -- On the afternoon of November 15th, the closing ceremony of the 2018 China Merchants Group "Building Blue Dreams Read more...

Weifa ASA Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 27092018] Prices from USD $250

SummaryWeifa ASA Weifa, formerly Aqualis ASA, is a pharmaceutical company that conducts the research and development, manufacture, distribution and sales of pharmaceutical products, lifestyle products and solutions. The company has over the counter OTC pharmaceutical market in Norway offering products for pain relief; treatment of cough and colds; dermatology; Nutraceuticals; dietary supplements; ...

Gilead Sciences Inc GILD Medical Equipment Deals and Alliances Profile [Report Updated: 16102018] Prices from USD $250

SummaryGilead Sciences Inc Gilead is a researchbased biopharmaceutical company. It focuses on the discovery, development and commercialization of medicines for the treatment of cardiovascular, hematological and respiratory diseases, inflammation, liver diseases, cancer and human immunodeficiency virus HIV infection. The company also has a wide range of pipeline products in different stages of deve...


Advertisement
Quick Search
Advertisement
Advertisement

 

News Quicklinks